129 related articles for article (PubMed ID: 32245205)
1. Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Ozutsumi T; Namisaki T; Shimozato N; Kaji K; Tsuji Y; Kaya D; Fujinaga Y; Furukawa M; Nakanishi K; Sato S; Sawada Y; Saikawa S; Kitagawa K; Takaya H; Kawaratani H; Kitade M; Moriya K; Noguchi R; Akahane T; Mitoro A; Yoshiji H
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245205
[TBL] [Abstract][Full Text] [Related]
2. The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory.
Pujadas G; De Nigris V; Prattichizzo F; La Sala L; Testa R; Ceriello A
Endocrine; 2017 Jun; 56(3):509-520. PubMed ID: 27530507
[TBL] [Abstract][Full Text] [Related]
3. Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms.
Cubero FJ; Nieto N
Hepatology; 2008 Dec; 48(6):2027-2039. PubMed ID: 19003881
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor.
Wakamatsu S; Jojima T; Hashiguchi M; Kishi H; Niitani T; Sakurai S; Iijima T; Kogai T; Tomaru T; Usui I; Aso Y
J Diabetes Complications; 2024 Jan; 38(1):108650. PubMed ID: 38035640
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of Ecklonia cava extract on high glucose-induced hepatic stellate cell activation.
Yokogawa K; Matsui-Yuasa I; Tamura A; Terada M; Kojima-Yuasa A
Mar Drugs; 2011 Dec; 9(12):2793-2808. PubMed ID: 22363250
[TBL] [Abstract][Full Text] [Related]
6. The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH.
Cervello M; Augello G; Cocco L; Ratti S; Follo MY; Martelli AM; Cusimano A; Montalto G; McCubrey JA
Adv Biol Regul; 2024 May; 92():101032. PubMed ID: 38693042
[TBL] [Abstract][Full Text] [Related]
7. Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model.
Song Y; Kim S; Heo J; Shum D; Lee SY; Lee M; Kim AR; Seo HR
Sci Rep; 2021 May; 11(1):10931. PubMed ID: 34035369
[TBL] [Abstract][Full Text] [Related]
8. The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model.
van Riet S; Julien A; Atanasov A; Nordling Å; Ingelman-Sundberg M
Hepatol Commun; 2024 Mar; 8(3):. PubMed ID: 38358377
[TBL] [Abstract][Full Text] [Related]
9. Friend or foe? The elusive role of hepatic stellate cells in liver cancer.
Cogliati B; Yashaswini CN; Wang S; Sia D; Friedman SL
Nat Rev Gastroenterol Hepatol; 2023 Oct; 20(10):647-661. PubMed ID: 37550577
[TBL] [Abstract][Full Text] [Related]
10. Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease.
van Son KC; Verschuren L; Hanemaaijer R; Reeves H; Takkenberg RB; Drenth JPH; Tushuizen ME; Holleboom AG
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831649
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and Fibrogenesis in Chronic Liver Diseases.
Bocca C; Novo E; Miglietta A; Parola M
Cell Mol Gastroenterol Hepatol; 2015 Sep; 1(5):477-488. PubMed ID: 28210697
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial Microgels for 3D ECM Screening and Heterogeneous Microenvironmental Culture of Primary Human Hepatic Stellate Cells.
Ryoo H; Giovanni R; Kimmel H; Jain I; Underhill GH
Adv Sci (Weinh); 2024 Apr; 11(15):e2303128. PubMed ID: 38348560
[TBL] [Abstract][Full Text] [Related]
13. Teneligliptin enhances the beneficial effects of GLP-1 in endothelial cells exposed to hyperglycemic conditions.
De Nigris V; Prattichizzo F; Mancuso E; Spiga R; Pujadas G; Ceriello A
Oncotarget; 2018 Feb; 9(10):8898-8910. PubMed ID: 29507662
[TBL] [Abstract][Full Text] [Related]
14. Sodium-glucose cotransporter 2 inhibitor canagliflozin attenuates lung cancer cell proliferation in vitro.
Yamamoto L; Yamashita S; Nomiyama T; Kawanami T; Hamaguchi Y; Shigeoka T; Horikawa T; Tanaka Y; Yanase T; Kawanami D; Iwasaki A
Diabetol Int; 2021 Oct; 12(4):389-398. PubMed ID: 34567921
[TBL] [Abstract][Full Text] [Related]
15. GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.
Columbano A; Chiellini G; Kowalik MA
Gene Expr; 2017 Nov; 17(4):265-275. PubMed ID: 28635586
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma, vascular endothelial growth factor receptors-targeting agents, and hypertension: A much more complicated relationship than expected.
Porta C; Negri F; Cosmai L
Cancer; 2024 Apr; 130(8):1208-1209. PubMed ID: 38280211
[No Abstract] [Full Text] [Related]
17. Combinatorial Microgels for 3D ECM Screening and Heterogeneous Microenvironmental Culture of Primary Human Hepatic Stellate Cells.
Ryoo H; Underhill GH
bioRxiv; 2023 May; ():. PubMed ID: 37214995
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of combination therapy of canagliflozin and teneligliptin on diabetic polyneuropathy and β-cell volume density in spontaneously type 2 diabetic Goto-Kakizaki rats.
Guo D; Mizukami H; Osonoi S; Takahashi K; Ogasawara S; Kudo K; Sasaki T; Yagihashi S
Metabolism; 2020 Jun; 107():154232. PubMed ID: 32302619
[TBL] [Abstract][Full Text] [Related]
19. Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E
Yoshino K; Hosooka T; Shinohara M; Aoki C; Hosokawa Y; Imamori M; Ogawa W
Biochem Biophys Res Commun; 2021 Jun; 557():62-68. PubMed ID: 33862461
[TBL] [Abstract][Full Text] [Related]
20. Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model.
Attia YM; Tawfiq RA; Gibriel AA; Ali AA; Kassem DH; Hammam OA; Elmazar MM
Biochem Pharmacol; 2021 Apr; 186():114497. PubMed ID: 33675775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
